<?xml version="1.0" encoding="UTF-8"?>
<drug type="biotech" created="2018-06-28" updated="2019-12-02">
  <drugbank-id primary="true">DB14148</drugbank-id>
  <name>Human albumin microspheres</name>
  <description/>
  <cas-number/>
  <unii>T8C6W1N6NW</unii>
  <groups>
    <group>approved</group>
    <group>experimental</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">Albumin human, microspheres</synonym>
    <synonym language="english" coder="">Albumin microsphere human serum</synonym>
    <synonym language="english" coder="">Albumin, microsphere human serum</synonym>
    <synonym language="english" coder="">Albumin,microsphere human serum</synonym>
    <synonym language="english" coder="">Human serum albumin microspheres</synonym>
    <synonym language="english" coder="">Protein-type A microspheres</synonym>
  </synonyms>
  <products>
    <product>
      <name>Optison Perflutren Protein-Type A Microspheres</name>
      <labeller>GE Healthcare Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0407-2707</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-01-02</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020899</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Optison Perflutren Protein-Type A Microspheres</name>
      <ingredients>Human albumin microspheres + Perflutren</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Ultrasound Contrast Activity</category>
      <mesh-id/>
    </category>
    <category>
      <category>Ultrasound Contrast Media</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <patents>
    <patent>
      <number>6723303</number>
      <country>United States</country>
      <approved>2004-04-20</approved>
      <expires>2021-04-20</expires>
      <pediatric-extension>false</pediatric-extension>
    </patent>
  </patents>
  <food-interactions/>
  <drug-interactions/>
  <sequences/>
  <experimental-properties/>
  <external-identifiers/>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>